ISSN: 0149-2918
Journal Home
Journal Guideline
Clinical Therapeutics Q2 Unclaimed
Clinical Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 140. It has an SJR impact factor of 0.824 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0.824.
Clinical Therapeutics focuses its scope in these topics and keywords: healthy, patients, treatment, chinese, pharmacokinetics, review, tolerability, combination, administered, randomized, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0.824
SJR Impact factor140
H Index223
Total Docs (Last Year)671
Total Docs (3 years)9203
Total Refs1919
Total Cites (3 years)590
Citable Docs (3 years)2.84
Cites/Doc (2 years)41.27
Ref/DocOther journals with similar parameters
Drug Safety - Case Reports Q2
Cancer Biology and Therapy Q2
Pharmacoepidemiology and Drug Safety Q2
Annals of Pharmacotherapy Q2
Current Cancer Drug Targets Q2
Compare this journals
Aims and Scope
Best articles by citations
A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy
View moreIntroduction
View moreViscosupplementation with Hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee
View moreCombination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of postoperative obstetric or gynecologic pain
View moreA randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients
View moreEarly onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients
View moreImpact of fears on quality of life in patients with a silent disease: osteoporosis
View moreDisposition of 14C-eptifibatide after intravenous administration to healthy men
View moreAzelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients
View moreAzelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone
View moreAn immunophilin-binding assay for sirolimus
View moreEditorial comment
View moreEditorial comment
View moreEditorial comment
View moreEditorial comment
View moreOutpatient costs of osteoporosis in a national health insurance population
View moreSumatriptan and lost productivity time: a time series analysis of diary data
View moreEditorial comment
View moreEditorial comment
View moreEditorial comment
View moreEditorial comment
View moreEditorial comment
View moreMedicare managed care: budgetary and tax implications
View moreEditorial comment
View more
Comments